CFTR mutation distribution among U.S. Hispanic and African American individuals: Evaluation in cystic fibrosis patient and carrier screening populations

Genetics in Medicine

Volumn 6, Issue 5, 2004, Pages 392-399

  Sugarman, Elaine A ^a,c   Rohlfs, Elizabeth M ^a   Silverman, Lawrence M ^b   Allitto, Bernice A ^a  

^a GENZYME CORPORATION   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Genzyme Genetics   (United States)

Author keywords

African American; Carrier screening; CFTR mutations; Cystic fibrosis; Hispanic

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ASHKENAZI JEW; ASIAN AMERICAN; AUTOSOMAL RECESSIVE DISORDER; CAUCASIAN; CFTR GENE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE CLASSIFICATION; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HISPANIC; HUMAN; INFANT; JEW; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL SOCIETY; MINORITY GROUP; MUTATION RATE; MUTATIONAL ANALYSIS; NEWBORN; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PREVALENCE; RACE DIFFERENCE; REVIEW; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; EVALUATION STUDIES; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HETEROZYGOTE DETECTION; HISPANIC AMERICANS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION; UNITED STATES;

EID: 4644298390     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000139503.22088.66     Document Type: Review

References (43)

1. Welsh MJ, Ramsey BW, Accurso F, Cutting GR. Cystic Fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2001:5121-5188.
2. Cystic Fibrosis Foundation. Available at: http://www.CFF.org/ Accessed April 21, 2004.
3. Hamosh A, Fitzsimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998;132:255-259.
4. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:456-461.
5. American College of Obstetricians and Gynecologists, and American College of Medical Genetics. 2001. Preconception and prenatal carrier screening for cystic fibrosis. Clinical and Laboratory Guidelines. American College of Obstetricians and Gynecologists, Washington, DC.
6. U.S. Census Bureau, American Fact Finder. People: Race and Ethnicity. Diversity Continues to Grow in the U.S., 2003. Available at: http://factfinder.census.gov Accessed April 2, 2004.
7. Garnirez RR, de la Cruz P. The Hispanic Population in the United States: March 2002.Washington DC, U.S. Census Bureau, June 2003. Current Population Reports, P20-545.
8. McKinnon J. The Black Population in the United States: March 2002. Washington, DC, U.S. Census Bureau, April 2003. Current Population Reports, P20-541.
9. Schmidley D. The Foreign-Born Population in the United States: March 2002. Washington, D.C., U.S. Census Bureau, February 2003, Current Population Reports, P20-539.
10. Richards CS, Bradley LA, Amos J, Allitto BA, Grody WW, Maddalena A et al. Standards and guidelines for CFTR mutation testing. Genet Med 2002;4:379-391.
11. Watson MS, Cutting GR, Desnick RJ, Driscoll D, Klinger K, Mennuti M et al. Cystic fibrosis (CF) Couple Carrier Screening: 2004 Revision of American College of Medical Genetics Mutation Panel, Genet Med 2004;6:387-391.
12. Gilbert F. Cystic fibrosis carrier screening: Steps in the development of a mutation panel. Genet Test 2001;5:223-227.
13. Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: A worldwide analysis of CFTR Mutations - Correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606.
14. Monaghan K, Bluhm D, Phillips M, Feldman GL. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals a higher carrier frequency and unanticipated frequencies for specific mutations. Genet Med 2004;6:141-144.
15. Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A et al. Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 1996;58:823-835.
16. Shuber A, Skoletsky J, Stern R, Handelin B, Efficient 12-mutation testing in the CFTR gene: A general model for complex mutation analysis. Hum Mol Genet 1993; 2:153-158.
17. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded pan-ethnic mutation panel. Genet Med 2001;3:168-176.
18. Kharrazi M, Alper O, Young S, Pearl M, Graham S, Lorey F et al. Cystic fibrosis transmembrane regulator mutations in Hispanic Californians with cystic fibrosis. Am J Hum Genet 2003;73(5):A1424,413.
19. Macek M Jr, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G et al. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 1997;60:1122-1127.
20. Kharrazi M. Genetic Disease Branch, California Department of Health Services. 2/2004. Available at: http://www.dhs.ca.gov/pcfh/gdb/html/PDE/ CFTablel.html Accessed April 8, 2004.
21. Kiesewetter S, Macek M, Davis C, Curristin SM, Chu C-S, Graham C et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993;5:274-278.
22. Massie RJH, Poplawski N, Wilcken B, Goldblatt J, Byrnes C, Robertson C. Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Eur Respir J 2001;17:1195-1200.
23. Feldmann D, Rochemaure J, Plouvier E, Magnier C, Chauve C, Aymard P. Mild course of cystic fibrosis in an adult with the D1152H mutation. Clin Chem 1995;45:1675.
24. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000;16:143-156.
25. Feldmann D, Coudere R, Audrezet MP, Ferec C, Bienvenu T, Desgeourges M et al. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum Mutat 2003;22:340-347.
26. Rozen R, Ferreira-Rajabi L, Robb L, Colman N. L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis. Am J Med Genet 1995;57:437-9.
27. Highsmith WE, Burch L, Zhou Z, Olsen IC, Boat TE, Spock A et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994;331:974-80.
28. Gilbert F, Li Z, Arzimanoglou I, Bialer M, Denning C, Gorvoy J et al. Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849+ 10kbC>T: Significance for geneticists. Am J Med Genet 1995;58:356-359. [erratum appears in Am J Med Genet 1996;64:527].
29. Gilbert F, Li Z, Arzimanoglou I, Bialer M, Denning C, Gorvoy J et al. Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849+ 10kbC>T: Significance for geneticists. Am J Med Genet 1995;58:356-359. [erratum appears in Am J Med Genet 1996;64:527].
30. Fanen P, Clain J, Labarthe R, Hulin P, Girodon E, Pagesy P et al. Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurringin disorders related to cystic fibrosis. FEBS Lett 1999;452:371-374.
31. Grieco EM, Cassidy RC. Overview of Race and Hispanic Origin: Census 2000 Brief, Washington, D.C. U.S. Census Bureau, March 2001.
32. Arzimanoglou I, Tuchman A, Li Z, Gilbert F, Denning C, Valverde K et al. Cystic fibrosis carrier screening in Hispanics. Am J Hum Genet 1995;56:544-547.
33. Wong LJC, Wang J, Zhang YH, Hsu E, Heim R, Bowman CM et al. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 2001;18:296-307.
34. Estivill X, Bancells C, Ramos C, Biomed CF. Mutation Analysis Consortium. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. Hum Mutat 1997;10:135-154.
35. Rohlfs EM, Sugarman EA, Heim RA, Allitto BA. Frequency of carriers of two cystic fibrosis mutations in an apparently unaffected adult population. Genet Med 2001;3:237.
36. Casals T, Bassas L, Ruiz-Romero J, Chillon M, Gimenex J, Ramos MD et al. Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected. Hum Genet 1995;95:205-211.
37. Padoa C, Goldman A, Jenkins T, Ramsay M. Cystic fibrosis carrier frequencies in populations of African origin, J Med Genet 1999;36:41-44.
38. Anguiano A, Oates R, Amos J, Dean M, Gerrard B, Stewart C et al. Congenital bilateral absence of the vas deferens: a primary genital form of cystic fibrosis. JAMA 1992;267:1794-1797.
39. Rohlfs EM, Zhou Z, Sugarman EA, Heim RA, Pace RG, Knowles MR et al.The I148T CFTR mutation confers a variable phenotype and occurs on multiple haplotypes. Am J Hum Genet suppl 2001:69A.
40. Strom CM, Huang D, Buller A, Redman J, Crossley B, Anderson B et al. Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples. Genet Med 2002;4:289-296.
41. Rohlfs EM, Zhou Z, Sugarman EA, Heim EI, Pace RG, Knowles MR et al. The I148T CFTR allele occurs on multiple haplotypes: A complex allele is associated with cystic fibrosis. Genet Med 2002;4:319-323.
42. Cystic Fibrosis Mutation Data Base, http://www.genet,sickkids,on.ca/cftr/ Accessed on May 23, 2003.
43. Gilbert F, Schoelkopf J, Zhen L, Arzimanoglou I, Shaham M, Udey J Ethnic inter-marriage and its consequences for cystic fibrosis carrier screening. Am J Prev Med 1995;11:251-255.